期刊文献+

加味五味消毒饮治疗社区获得性肺炎(痰热壅肺)疗效观察

下载PDF
导出
摘要 目的研究加味五味消毒饮合并西药治疗社区获得性肺炎(痰热壅肺)的疗效,并观察其症状及炎性指标的变化。方法取在我院就诊并确诊为社区获得性肺炎(CAP)患者126例,按指南规定进行治疗,并随机分为两组,中西医结合组服用加味五味消毒饮汤剂,西药对照组单纯使用指南推荐治疗方案;治疗3天,治疗前后分别检查患者胸部CT,血WBC、GR%、CRP,观察前后症状改善情况。结果中西医结合组单项症状和各项炎性指标治疗均较西药对照组显著改善。结论使用加味五味消毒饮中西医结合治疗CAP有较好辅助作用,能改善症状,降低炎性因子的水平。
出处 《海峡药学》 2012年第3期101-103,共3页 Strait Pharmaceutical Journal
  • 相关文献

参考文献10

  • 1Fine MJ,Hanusa BH,Lave JR. Comparison of a disease-specific and a generic severity of illness measure for patients with communityacquired pneumonia[J].Journal of General Internal Medicine,1995.359-368.
  • 2社区获得性肺炎诊断和治疗指南[J].中华结核和呼吸杂志,2006,29(10):651-655. 被引量:3061
  • 3田德禄;单兆伟;黄永生.中医内科学[M]北京:人民卫生出版社,200259-65.
  • 4国家中医药管理局.中医病证诊断疗效标准[M]南京:南京大学出版社,19942.
  • 5李蔚林,董德寅,刘军.加味五味消毒饮治疗对粒细胞移行性变化的研究[J].青海医药杂志,1998,28(11):11-12. 被引量:7
  • 6石学魁,李英兰,宋宝辉,董艳,于新慧,梁忆红,刘亚威,乔建成.五味消毒饮增强小鼠免疫功能及调整菌群失调的影响[J].牡丹江医学院学报,2000,21(3):7-9. 被引量:9
  • 7余荣环,臧国庆,刘刚,乐魏列.白细胞不增高的社区获得性肺炎病原分析及临床特征[J].中国临床医学,2004,11(2):156-158. 被引量:12
  • 8PARAN Y,YABLECOVITCH D,CHOSHEN G. C-reactive protein velocity to distinguish febrile bacterial infections from nonbacterial febrile illnesses in the emergency department[J].Critical Care,2009,(02):R50.doi:10.1186/cc7775.
  • 9BELLMANN-WEILER R,AUSSERWINKLER M,KURZ K. Clinical Potential of C-Reactive Protein and Procalcitonin Serum Concentrations To Guide Differential Diagnosis and Clinical Management of Pneumococcal and Legionella Pneumonia[J].Journal of Clinical Microbiology,2010,(05):1915-1917.
  • 10MENENDEZ R,CAVALCANTI M,REYES S. Markers of treatment failure in hospitalized community-acquired Pneumonia[J].Thorax,2008,(05):447-452.doi:10.1136/thx.2007.086785.

二级参考文献32

  • 1沈定霞,罗燕萍,崔岩,赵莉萍,白立彦.分离产金属β-内酰胺酶的铜绿假单胞菌[J].中华医院感染学杂志,2004,14(1):86-88. 被引量:109
  • 2刘又宁,陈民钧,赵铁梅,王辉,王睿,刘庆锋,蔡柏蔷,曹彬,孙铁英,胡云建,修清玉,周新,丁星,杨岚,卓建生,唐英春,张扣兴,梁德荣,吕晓菊,李胜歧,刘勇,俞云松,魏泽庆,应可净,赵峰,陈萍,侯晓娜.中国城市成人社区获得性肺炎665例病原学多中心调查[J].中华结核和呼吸杂志,2006,29(1):3-8. 被引量:789
  • 3Bartlett JG, Breiman RF, Mandell LA, et al. Community - acquired pneumonia in adults: guidelines for management. The Infectious Diseases Socity of America. Clin Infect Dis, 1998,26:811-838.
  • 4Ramirez JA. Community - acquired pneumonia in adults. Prim Care, 2003,30(1) :155-171.
  • 5Wattanathum A, Chaoprasong C, Nunthapisud P, et al. Community- acquired pneumonia in southeast Asia: the microbial differences between ambulatory and hospitalized patients. Chest,2003; 123(5) :1512-1519.
  • 6Lieberman D, Schlaeffer F, Boldur I, et al. Multiple pathogens in adult patients admitted with community- acquired pneumonia:a one year prospective study of .346 consecutive patients. Thorax, 1996,51:179-184.
  • 7Lim WS, Macfarlane JT,Boswell TCJ,et al. Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines. Thorax,2001,56:296-301.
  • 8Ngeow YF,Suwanjutha S,Chantarojanasriri T,et al.An Asian study on the prevalence of atypical respiratory pathogens in community-acquired pneumonia.Int J Infect Dis,2005,9:144-153.
  • 9de Roux A,Marcos MA,Garcia E,et al.Viral community-acquired pneumonia in nonimmunocompromised adults.Chest,2004,125:1343-1351.
  • 10Ostrosky-Zeichner L,Alexander BD,Kett DH,et al.Multicenter clinical evaluation of the (1→3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans.Clin Infect Dis,2005,41:654-659.

共引文献3078

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部